OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - BIO-RAD LABORATORIES Share Price

Certificat

DE000SN8MNX5

Market Closed - Deutsche Boerse AG 01:12:19 01/06/2024 am IST
2.77 EUR -1.07% Intraday chart for OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - BIO-RAD LABORATORIES
Current month-6.10%
1 month-6.10%
Date Price Change
31/24/31 2.77 -1.07%
30/24/30 2.8 +1.08%
29/24/29 2.77 +0.36%
28/24/28 2.76 +0.73%
27/24/27 2.74 -.--%

Delayed Quote Deutsche Boerse AG

Last update May 01, 2024 at 01:12 am IST

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying BIO-RAD LABORATORIES, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SN8MNX
ISINDE000SN8MNX5
Date issued 25/08/2022
Strike 586.2 $
Maturity Unlimited
Parity 100 : 1
Emission price 0.94
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.01
Lowest since issue 0.62

Company Profile

Bio-Rad Laboratories, Inc. is specialized in the development, manufacturing and marketing of products used in life sciences research, clinical diagnostics and analytical chemistry. Net sales break down by activity as follows: - manufacture of clinical diagnostic tests and automated test systems (51.8%). The group also offers test kits, quality control systems and related IT systems; - manufacture of reagents, equipment and instruments for biological research (48.1%): for the separation, identification and purification of chemical and biological substances (proteins, nucleic acids, bacteria, etc.) for the proteomics, genomics research, biopharmaceuticals, cell biology and food safety markets; - other (0.1%): in particular, manufacturing of analytical instruments. At the end of 2022, the Group has 16 production sites in the United States (5), Germany (3), France (2), China (2), Poland, the United Kingdom, Switzerland and Singapore. Net sales are distributed geographically as follows: the United States (41.2%), Europe (30.4%), Asia (22.8%) and other (5.6%).
Sector
-
More about the company

Ratings for Bio-Rad Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Bio-Rad Laboratories, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
286.9 USD
Average target price
393.8 USD
Spread / Average Target
+37.28%
Consensus